The Effect of a High-Fat Breakfast on the Pharmacokinetics of Moxidectin in Healthy Male Subjects: A Randomized Phase I Trial
Authors:
- Joan M. Korth-BradleyJKJoan M. Korth-Bradley
- Virginia ParksVPVirginia Parks
- Stephan ChalonSCStephan Chalon
- Ian GourleyIGIan Gourley
- Kyle MatschkeKMKyle Matschke
- Karine CailleuxKCKarine Cailleux
- Serge FitoussiSFSerge Fitoussi
- Lawrence FleckensteinLFLawrence Fleckenstein
Open Access
- 1 January 2012
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 86 (1) , 122-125
Abstract
The objective of this study was to assess the effect of a high-fat meal on the pharmacokinetics of moxidectin. Healthy male subjects were randomized to receive single oral 8 mg doses of moxidectin after an overnight fast or high-fat breakfast. In fasted subjects (N = 27), mean [SD] parameters were Cmax: 58.9 [12.5] ng/mL; tmax: 3.7 [1.5] h; area under concentration-time curve (AUC): 3,387 [1,328] ng/h/mL; Vλz/F: 2,829 [1,267] L; CL/F: 2.76 [1.28] L/h; and t½: 784 [347] h. Compared with fasted subjects, fed subjects (N = 27) exhibited a 34% increase in Cmax, delay in tmax to 5.3 [2.1] h, 44% increase in AUC, 40% decrease in Vλz/F, and a 35% decrease in CL/F. There was no significant change in t½. The changes are consistent with an increase in moxidectin bioavailability following administration with food. There were no clinically relevant changes in vital signs, laboratory tests, or electrocardiograms.Keywords
This publication has 10 references indexed in Scilit:
- Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic MoxidectinClinical Pharmacology in Drug Development, 2012
- Effect of a high-fat meal on absorption and disposition of lipophilic compounds: The importance of degree of association with triglyceride-rich lipoproteinsEuropean Journal of Pharmaceutical Sciences, 2007
- Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification SystemPharmaceutical Research, 2005
- The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in HumansThe Journal of Clinical Pharmacology, 2003
- Liquid chromatographic assay of moxidectin in human plasma for application to pharmacokinetic studiesJournal of Pharmaceutical and Biomedical Analysis, 2002
- A glutamate-gated chloride channel subunit from Haemonchus contortus:Biochemical Pharmacology, 2002
- Population biology of human onchocerciasisPhilosophical Transactions of the Royal Society B: Biological Sciences, 1999
- Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegansNature, 1994
- Absorption, Tissue Distribution, Metabolism, and Excretion of Moxidectin in CattleJournal of Agricultural and Food Chemistry, 1994
- The reproductive lifespan of Onchocerca volvulus in West African savannaActa Tropica, 1991